Trials / Completed
CompletedNCT01393457
Cognitive Remediation for Cocaine Dependence
Cognitive-enhancing DA Medications for Cocaine Dependence
- Status
- Completed
- Phase
- Phase 2
- Study type
- Interventional
- Enrollment
- 119 (actual)
- Sponsor
- The University of Texas Health Science Center, Houston · Academic / Other
- Sex
- All
- Age
- 18 Years – 55 Years
- Healthy volunteers
- Not accepted
Summary
The purpose of this study is to evaluate treatments designed to improve cocaine treatment success by combining medications that target cocaine-related cognitive impairments.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | levodopa/carbidopa | 800/200 mg/d |
| DRUG | Ropinirole 2 mg/d | 2 mg/d |
| DRUG | Placebo | sugar pill |
| DRUG | Ropinirole 4 mg/d | 4 mg/d |
Timeline
- Start date
- 2011-06-01
- Primary completion
- 2017-02-01
- Completion
- 2017-02-01
- First posted
- 2011-07-13
- Last updated
- 2018-03-29
- Results posted
- 2018-03-29
Locations
1 site across 1 country: United States
Source: ClinicalTrials.gov record NCT01393457. Inclusion in this directory is not an endorsement.